Webcast is Live at 4 p.m. (CT)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Jan. 22, 2019--
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in
vitro diagnostic technologies to the healthcare industry, today
announced that it will host a live webcast of its first quarter fiscal
2019 conference call on Wednesday, January 30, at 4 p.m. CT (5 p.m. ET).
The Company will issue an earnings news release after the market closes
that afternoon.
Gary Maharaj, president and chief executive officer, and Tim Arens,
interim vice president of finance and chief financial officer, will
recap the first quarter fiscal 2019 financial results and
accomplishments. To access the webcast, go to the investor relations
portion of the Company’s website at https://surmodics.gcs-web.com
the day of the conference call and click on the webcast icon.
An audio replay will be available beginning at 7 p.m. CT on Wednesday,
January 30, until 7 p.m. CT on Wednesday, February 6, and can be
accessed by dialing 888-203-1112 and entering conference call ID
passcode 1070221. In addition, the conference call audio and transcript
will be archived on the Company’s website following the call.
About Surmodics, Inc.
Surmodics is the global leader in surface modification technologies for
intravascular medical devices and a leading provider of chemical
components for in vitro diagnostic (IVD) immunoassay tests
and microarrays. Surmodics is pursuing highly differentiated
whole-product solutions that are designed to address unmet clinical
needs for its medical device customers and engineered to the most
demanding requirements. This key growth strategy leverages the
combination of the Company’s expertise in proprietary surface
technologies, along with enhanced device design, development and
manufacturing capabilities. The Company mission remains to improve the
detection and treatment of disease. Surmodics is headquartered in Eden
Prairie, Minnesota. For more information, visit www.surmodics.com. The
content of Surmodics’ website is not part of this press release or part
of any filings that the company makes with the SEC.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190122005219/en/
Source: Surmodics, Inc.
Tim Arens
952-500-7000
ir@surmodics.com
